Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD Market Closed
Market Cap: 575.6m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ACCD stock under the Base Case scenario is 9.83 USD. Compared to the current market price of 7.02 USD, Accolade Inc is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACCD Relative Value
Base Case
9.83 USD
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
0
vs Industry
59
Median 3Y
1.3
Median 5Y
1.3
Industry
2.2
Forward
1.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.2
Industry
21.9
Forward
-4.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-84.3
Median 5Y
-84.3
Industry
14
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-40.6
Median 5Y
-40.6
Industry
19.7
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
0
vs Industry
45
Median 3Y
1.8
Median 5Y
1.8
Industry
2.1
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
0
vs Industry
61
Median 3Y
1.2
Median 5Y
1.2
Industry
2.3
Forward
1.2
More Details
2.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.6
vs History
0
vs Industry
63
Median 3Y
2.6
Median 5Y
2.6
Industry
4.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.7
Median 5Y
-12.7
Industry
11.5
Forward
32.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-6.4
Industry
15.7
Forward
-5.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-81.9
Median 5Y
-81.9
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-43.5
Median 5Y
-43.5
Industry
17.4
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
0
vs Industry
49
Median 3Y
1.4
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

ACCD Competitors Multiples
Accolade Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Accolade Inc
NASDAQ:ACCD
569.9m USD 1.3 -3.2 -12.6 -6.4
US
Cigna Corp
NYSE:CI
85.1B USD 0.3 16.9 8.3 10.7
US
Cigna Group
XMUN:CGN
73.7B EUR 0.3 16.8 8.3 10.6
US
CVS Health Corp
NYSE:CVS
85B USD 0.2 16.1 13.1 13.1
DE
Fresenius Medical Care AG
XMUN:FME
27.2B EUR 1.4 44.9 11.7 25.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.7B EUR 1.1 56.2 10.3 16.7
US
Laboratory Corporation of America Holdings
NYSE:LH
22B USD 1.7 30.2 15.2 23.9
US
Quest Diagnostics Inc
NYSE:DGX
20.2B USD 2 22.7 13.1 17.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.9B EUR 0.7 22.4 7.3 15.7
US
Hims & Hers Health Inc
NYSE:HIMS
13.6B USD 7.6 83.7 95.9 114.5
US
DaVita Inc
NYSE:DVA
10.6B USD 0.8 12.2 7.4 10.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Accolade Inc
NASDAQ:ACCD
Average EV/EBITDA: 19.1
Negative Multiple: -12.6 		N/A N/A
US
Cigna Corp
NYSE:CI
8.3
4%
2.1
US
C
Cigna Group
XMUN:CGN
8.3
4%
2.1
US
CVS Health Corp
NYSE:CVS
13.1
25%
0.5
DE
Fresenius Medical Care AG
XMUN:FME
11.7
11%
1.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.3
13%
0.8
US
Laboratory Corporation of America Holdings
NYSE:LH
15.2
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
13.1
8%
1.6
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
7.3
11%
0.7
US
Hims & Hers Health Inc
NYSE:HIMS
95.9
86%
1.1
US
DaVita Inc
NYSE:DVA
7.4
4%
1.8

See Also

Summary
ACCD intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACCD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACCD stock valuation using valuation multiples.
Wall Street Estimates
ACCD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACCD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.